FIELD: chemical-pharmaceutical industry.
SUBSTANCE: invention refers to methods of extracting leukocyte peptides from raw material of animal origin, which can be used as biologically active substances when producing pharmaceutical compositions. Method of extracting leukocyte peptides involves homogenisation of human donor raw material, centrifugation, followed by sterilizing filtration of the obtained substance through fine-pore filters. Human donor raw material used is leukocytes in physiological saline, which are subjected to ultrasound treatment at amplitude of 60 to 80 % for 60 to 120 seconds.
EFFECT: invention enables to obtain protein fractions having a simple method of antibacterial and antiviral properties.
1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EXTRACTING NATURAL ANTIMICROBIAL PEPTIDES FROM LEUKOCYTE-ERYTHROCYTE-PLATELET BLOOD MASS | 2019 |
|
RU2729016C1 |
METHOD OF ISOLATING ENDOGENOUS ANTIMICROBIAL PEPTIDES FROM PLACENTAL TISSUE | 2022 |
|
RU2813979C2 |
OPTIMIZED RELEASE OF ENDOGENOUS BETA-DEFENSINS | 2024 |
|
RU2825572C1 |
SEPARATION METHOD OF LOW-MOLECULAR PEPTIDES | 2012 |
|
RU2510398C2 |
METHOD OF EXTRACTING LOW MOLECULAR PEPTIDES | 2008 |
|
RU2416243C2 |
PREPARATION "LOCFERON" FOR TREATMENT AND PROPHYLAXIS OF VIRAL DISEASES AND A METHOD OF ITS PREPARING | 1997 |
|
RU2108804C1 |
METHOD OF SEPARATING MIXTURE OF DNA AND PROTEINS FROM EPIMASTIGOTE FORMS OF Trypanosoma cruzi | 2013 |
|
RU2558235C2 |
METHOD OF PRODUCING BIOLOGICALLY ACTIVE PEPTIDE-AMINO ACID PREPARATION BASED ON HUMAN BLOOD PLASMA | 2022 |
|
RU2799637C1 |
METHOD OF PREPARING THE PREPARATION FOR ANTIINFECTIOUS IMMUNOTHERAPY | 1991 |
|
RU2076715C1 |
METHOD OF PREPARING PRODUCT CONTAINING IMMUNOGLOBULINS G, A, M (VERSIONS) | 2009 |
|
RU2429015C2 |
Authors
Dates
2020-12-02—Published
2019-05-13—Filed